The United Kingdom has authorized the first ever covid-19 vaccine for Omicron variant. It is the first country to do so. Authorization of vaccine will now pave ways...
Researchers from Indian Institute of Science (IISc) recently conducted an experiment to inactivate the SARS-CoV-2 virus, in collaboration with the CSIR-Institute of Microbial Technology. Key Facts Researchers found...
Researchers from University of Helsinki have developed a molecule, that can inactivate the coronavirus spike protein. It also offers effective short-term protection against the coronavirus. About TriSb92 Molecule...
According to Chinese researchers, a type of coronavirus called NeoCov, which spreads among bats in South Africa is likely to pose threat to humans if it mutates further, in...
Researchers from IIT Delhi’s Kusuma School of Biological Sciences have developed an RT-PCR based test, that can detect Omicron variant of SARS-CoV-2 in 90 minutes. Key Points The...
On November 29, 2021, World Health Organization (WHO) warned that; the new variant of SARS-CoV-2 virus called “Omicron” poses very high global risk. Highlights Early evidence shows that,...
The World Health Organisation (WHO) designated SARS-CoV-2 variant B.1.1529 as a ‘variant of concern’. Key Points This variant of SARS-CoV-2 has been named as Omicron. This variant was first...
A new study from US shows that white-tailed deer are being infected with SARS-CoV-2, the virus causing COVID-19 in humans. Key Points During the study, Antibodies were found in 40% of deer....
The Subject Expert Committee on Covid-19 has approved the “emergency use” of Bharat Biotech’s Covaxin vaccine for children aged between 2-18 years old. Key Points Phase-2 and Phase-3...
European Medicines Agency (EMA) approved the booster doses of Pfizer/BioNTech Covid-19 vaccine for people aged 18 and above on October 4, 2021. Key Facts This approval given as...
